Focus Partners Advisor Solutions LLC Raises Holdings in Omega Healthcare Investors, Inc. $OHI

Focus Partners Advisor Solutions LLC lifted its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 5.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,483 shares of the real estate investment trust’s stock after buying an additional 528 shares during the period. Focus Partners Advisor Solutions LLC’s holdings in Omega Healthcare Investors were worth $384,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of OHI. AQR Capital Management LLC raised its stake in shares of Omega Healthcare Investors by 430.8% during the 1st quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust’s stock worth $108,989,000 after buying an additional 2,322,878 shares in the last quarter. Vanguard Group Inc. increased its holdings in Omega Healthcare Investors by 3.9% in the first quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust’s stock valued at $1,506,250,000 after buying an additional 1,492,904 shares in the last quarter. Invesco Ltd. increased its stake in Omega Healthcare Investors by 122.3% in the 1st quarter. Invesco Ltd. now owns 2,416,560 shares of the real estate investment trust’s stock valued at $92,023,000 after purchasing an additional 1,329,324 shares in the last quarter. Nuveen LLC purchased a new position in Omega Healthcare Investors in the 1st quarter valued at approximately $42,513,000. Finally, Caisse DE Depot ET Placement DU Quebec increased its stake in Omega Healthcare Investors by 163.5% in the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,371,945 shares of the real estate investment trust’s stock valued at $52,244,000 after purchasing an additional 851,299 shares in the last quarter. 65.25% of the stock is owned by hedge funds and other institutional investors.

Omega Healthcare Investors Price Performance

Shares of NYSE:OHI opened at $39.91 on Friday. The business has a fifty day simple moving average of $41.47 and a 200-day simple moving average of $39.08. Omega Healthcare Investors, Inc. has a 52 week low of $35.04 and a 52 week high of $44.42. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. The company has a market cap of $11.77 billion, a P/E ratio of 24.64, a P/E/G ratio of 1.85 and a beta of 0.70.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.77 by $0.02. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The firm had revenue of $260.74 million during the quarter, compared to the consensus estimate of $262.48 million. During the same quarter in the previous year, the business earned $0.71 earnings per share. The firm’s quarterly revenue was up 14.4% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. Equities research analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Monday, November 3rd will be paid a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.7%. The ex-dividend date of this dividend is Monday, November 3rd. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 165.43%.

Analyst Ratings Changes

Several equities analysts recently weighed in on OHI shares. Truist Financial raised their price objective on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a “hold” rating in a research note on Wednesday, September 3rd. Royal Bank Of Canada raised their price objective on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a “sector perform” rating in a research note on Thursday, August 7th. Scotiabank lifted their target price on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a “sector perform” rating in a research report on Thursday, August 28th. Raymond James Financial restated an “outperform” rating on shares of Omega Healthcare Investors in a research report on Tuesday, September 2nd. Finally, Wells Fargo & Company lifted their target price on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 21st. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $43.86.

Insider Buying and Selling at Omega Healthcare Investors

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of Omega Healthcare Investors stock in a transaction on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the transaction, the director owned 18,654 shares in the company, valued at approximately $749,144.64. The trade was a 11.82% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.50% of the company’s stock.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.